Posted on 26/10/2009 in Veterinary Supplier News Idexx, a firm that provides products to the veterinary market, has published its financial results for the third quarter of 2009.
The firm revealed that its revenue during this period stood at $259.1 million (158.9 million pounds), compared to $251.1 million for the third quarter of 2008.
Additionally, its earnings per diluted share for the quarter ended September 30th 2009 grew by 24 per cent to 52 cents from 42 cents during the corresponding period of last year.
"Our overall performance varied by line of business and geography, but our core companion animal businesses achieved solid organic growth worldwide," stated Jonathan Ayers, chief executive officer of Idexx.
He added that the firm expects to see a strong end to the year in both its European and North American markets.
Idexx's financial update comes after the firm announced the launch of its Fecal Egg Count Test - a product designed to assist equine practitioners to better monitor the progress of de-worming courses.
Other news stories from 26/10/2009
Read more in the Zenopa News Archive
How this news is generated
|
